These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 39083)

  • 21. [Pseudohypoaldsteronism. A further case report (author's transl)].
    Stubbe P; Manouguian G
    Monatsschr Kinderheilkd (1902); 1977 Apr; 125(4):234-7. PubMed ID: 857148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of salt-losing among congenital adrenal hyperplasia patients.
    Fife D; Rappaport EB
    Clin Endocrinol (Oxf); 1983 Aug; 19(2):259-64. PubMed ID: 6883739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Bey-Omar F; Feit JP; Forest MG; David M
    Pediatrie; 1983 Mar; 38(2):77-86. PubMed ID: 6622141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; Berglind N; Wilson RC; New MI
    J Clin Endocrinol Metab; 2007 Jan; 92(1):137-42. PubMed ID: 17032723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Congenital adrenal hyperplasia: clinical aspects and neonatal screening].
    Stikkelbroeck MM; Otten BJ
    Ned Tijdschr Geneeskd; 2002 Feb; 146(6):246-9. PubMed ID: 11865652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
    Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital adrenal hyperplasia - how to improve the transition from adolescence to adult life.
    Kruse B; Riepe FG; Krone N; Bosinski HA; Kloehn S; Partsch CJ; Sippell WG; Mönig H
    Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):343-55. PubMed ID: 15239019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical use of fludrocortisone acetate in congenital adrenal hyperplasia. Effect on plasma renin activity and aldosterone (author's transl)].
    Tokuhiro E; Suwa S; Maesaka H
    Horumon To Rinsho; 1980; 28(3):345-51. PubMed ID: 6994941
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Horner JM; Hintz RL; Luetscher JA
    J Clin Endocrinol Metab; 1979 May; 48(5):776-83. PubMed ID: 219009
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of stage IV neuroblastoma in a child with congenital adrenal hyperplasia (CAH): a case report and review of literature.
    Lashkari HP; Aabideen K; Albanese A; Vaidya S
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):e186-7. PubMed ID: 22713710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone secretion rate in the hypertensive form of congenital adrenal hyperplasia.
    Kowarski A; Russell A; Migeon CJ
    J Clin Endocrinol Metab; 1968 Oct; 28(10):1445-9. PubMed ID: 5681639
    [No Abstract]   [Full Text] [Related]  

  • 32. Salt-losing in an infant with congenital adrenal hyperplasia and normal aldosterone production.
    Visser HK; Degenhart HJ
    Acta Paediatr Scand; 1967 Mar; 56(2):216-20. PubMed ID: 6049804
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fluid and electrolyte disorders associated with alcoholism].
    Shimizu K; Yamada K
    Nihon Rinsho; 1997 Feb; 55 Suppl():210-9. PubMed ID: 9078735
    [No Abstract]   [Full Text] [Related]  

  • 34. Sodium homeostasis and aldosterone secretion in salt-losing congenital adrenal hyperplasia.
    Keenan BS; Holcombe JH; Kirkland RT; Potts VE; Clayton GW
    J Clin Endocrinol Metab; 1979 Mar; 48(3):430-6. PubMed ID: 429496
    [No Abstract]   [Full Text] [Related]  

  • 35. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hitherto unreported case of 21-hydroxylase deficiency associated with Bartter's syndrome and a balanced 6-9 translocation.
    Yabe R; Mizuno K; Ojima M; Ogawa S; Tani M; Niimura S; Watari H; Kunii N; Suenaga K; Yatabe Y
    J Med; 1987; 18(5-6):333-49. PubMed ID: 3333163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate.
    Casteràs A; De Silva P; Rumsby G; Conway GS
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):833-7. PubMed ID: 19250265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.
    Marra AM; Improda N; Capalbo D; Salzano A; Arcopinto M; De Paulis A; Alessio M; Lenzi A; Isidori AM; Cittadini A; Salerno M
    J Clin Endocrinol Metab; 2015 Feb; 100(2):644-52. PubMed ID: 25405496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney function in mice lacking aldosterone.
    Makhanova N; Lee G; Takahashi N; Sequeira Lopez ML; Gomez RA; Kim HS; Smithies O
    Am J Physiol Renal Physiol; 2006 Jan; 290(1):F61-9. PubMed ID: 16118390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital adrenal hyperplasia in adulthood: do men need to continue treatment?
    Mönig H; Sippell W
    Horm Res; 2005; 64 Suppl 2():71-3. PubMed ID: 16286776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.